Pediatric Obesity

Treating pediatric Obesity
Treating pediatric Obesity

Treating Pediatric Obesity The American Academy of Pediatrics said aggressive obesity interventions would not fuel eating disorders But authors of the relevant studies say the academy misconstrued or wrongly cited their work A drug approved to treat obesity in adults and teens is safe and effective for use in kids as young as 6, when combined with diet and exercise

childhood obesity And Cardiovascular Disease Risk Working Toward
childhood obesity And Cardiovascular Disease Risk Working Toward

Childhood Obesity And Cardiovascular Disease Risk Working Toward Children who used the weight loss drug liraglutide in a late-stage trial lost significantly more weight than children who got a placebo, according to a new study The first trial of a GLP-1 in children 6-12 showed it was effective, but raises questions about whether the benefits of weight loss justify giving daily medication to children so young Children with hidradenitis suppurativa (HS) are more likely to have obesity than those without the condition, a review suggests Amid an ongoing debate over what role, if any, GLP-1 medications should play in treating children who are still in elementary school, researchers have concluded that a Novo Nordisk obesity drug may be

Comments are closed.